NTBLQ — Notable Labs Balance Sheet
0.000.00%
- $0.00m
- -$3.79m
- $0.31m
Annual balance sheet for Notable Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 36.5 | 30.3 | 53.1 | 20.7 | 11.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.629 | 0.322 | 0.465 | 0.102 | 0.186 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 37.8 | 32 | 54.8 | 22.1 | 15.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.1 | 8.76 | 8.86 | 7.14 | 2.35 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 49 | 41.7 | 64.7 | 29.7 | 19.5 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.67 | 7.46 | 9.93 | 6.73 | 2.74 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 13 | 10.8 | 12.5 | 7.21 | 4.43 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 36 | 30.9 | 52.2 | 22.5 | 15.1 |
Total Liabilities & Shareholders' Equity | 49 | 41.7 | 64.7 | 29.7 | 19.5 |
Total Common Shares Outstanding |